Stockreport

Individual investors account for 50% of Corvus Pharmaceuticals, Inc.'s (NASDAQ:CRVS) ownership, while private equity firms account for 16% [Yahoo! Finance]

Corvus Pharmaceuticals, Inc.  (CRVS) 
Last corvus pharmaceuticals, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corvuspharma.com
PDF The top 25 shareholders own 49% of the company Institutions own 15% of Corvus Pharmaceuticals Every investor in Corvus Pharmaceuticals, Inc. ( NASDAQ:CRVS ) should [Read more]